Back
Calumet Specialty Products Partners LP 10K Form
Buy
59
CLMT
Calumet Specialty Products Partners LP
Last Price:
16.20
Seasonality Move:
7.44%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CLMT News And Ratings
See the #1 stock for the next 7 days that we like better than CLMT
CLMT Financial Statistics
Sales & Book Value
| Annual Sales: | $4.18B |
|---|---|
| Cash Flow: | $-39M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-6.13 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | 0.79000 |
|---|---|
| Net Income (TTM): | $48.1M |
| Gross Margin: | $451.7M |
| Return on Equity: | 0% |
| Return on Assets: | 1.74% |
Calumet Specialty Products Partners LP Earnings Forecast
Key Calumet Specialty Products Partners LP Financial Ratios
- The Gross Profit Margin over the past 23 years for CLMT is 10.80%.
- The Selling, General & Administrative Expenses for CLMT have been equal to 4.49% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 460.91% of Operating Income.
- The Net Earning history of CLMT is 1.15% of Total Revenues.
- Per Share Earnings over the last 23 years have been positive in 11 years.
Calumet Specialty Products Partners LP Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Oil, Gas & Consumable Fuels |
| Sector: | Energy |
| Current Symbol: | CLMT |
| CUSIP: | 131476 |
| Website: | calumetspecialty.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0.71 |
| Quick Ratio: | 0.26 |
Price-to-Earnings
| Trailing P/E Ratio: | 27.46 |
|---|---|
| Forward P/E Ratio: | 8.8 |
CLMT Technical Analysis vs Fundamental Analysis
Buy
59
Calumet Specialty Products Partners LP (CLMT)
is a Buy
Is Calumet Specialty Products Partners LP a Buy or a Sell?
-
Calumet Specialty Products Partners LP stock is rated a Buy
The current Calumet Specialty Products Partners LP [CLMT] share price is $16.20. The Score for CLMT is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.